Pinned Tweet
“The Last Shift”
Oil on clay covered wood board by C. Michael Gibson 2020.
Welcome home to all of our courageous #CoronaHeroes who made the ultimate sacrifice 🙏💙
#cmgsees #COVID19
Intensive LDL-C lowering reduces cardiovascular risk in patients with impaired kidney function: Evolocumab reduced the risk of 3-point MACE by 39% and 4-point MACE by 23% in patients with reduced eGFR with NNTs of 20-25 in the Vesalius CV trial.
Dr. Jan Cornel and I discuss the findings.
Watch video here: clinicaltrialresults.org/wp-…
Tune in! @MarcBonaca and @CMichaelGibson discuss the functional effects and patient progress with once-weekly semaglutide for type 2 diabetes and PAD. Listen to the full podcast here: bit.ly/4fctirC
C. Michael Gibson MD retweeted
Meal caused anaphylaxis in a @Lufthansa flight attendant. I thought of Jason Hu, who died at 16 after airline meal. This time, an ICU doc drew up epi from vial & plane diverted. What if they’d been over the ocean?These ? & more I take up in my new @AllergicLiving article, plus @FAANews new rule why falls short & why crews need easy to use epi & hands-on training.
allergicliving.com/2026/11/1… @RealDoctorMike @tmprowell @CMichaelGibson @SenDuckworth @SenSchumer @amyfaithho @DrIanWeissman @DrEliDavid @phylogenomics @airlinegossip @davidshepardson @HenMazzig @susannareid100
C. Michael Gibson MD retweeted
My discussion with @CMichaelGibson who in addition to being a world renowed cardiologist and clinical trialist is also a patient with elevated Lp(a). Some accompanying slides for our discussion. @hsbhatia @UCSDHealth @VietHeartPA @DrMarthaGulati @DLBHATTMD @dranulala @hvanspall @JamalRanaMD @nationallipid @MWilkinsonMD @FamilyHeartFdn @IdoAviviMD @DavidLBrownMD @CMHC_CME @escardio @CardioNerds @rblument1 @iamritu @Bweber04 @RonBlankstein @BudoffMd @ProfKausikRay @MonSangh @HeartDocSadiya @EugeniaGianos @DrEugeneYang @DrNathanWong
Following the highly anticipated HORIZON trial results presented at AHA 2026, what do the findings mean for cardiovascular prevention, clinical guidelines, and everyday practice?
Dr. Pam Taub and I discuss the implications of the HORIZON findings, the evolving evidence surrounding Lp(a), and what clinicians should consider moving forward.
Watch video here: clinicaltrialresults.org/wp-…
C. Michael Gibson MD retweeted
What a fabulous discussion between the Master Interviewer @CMichaelGibson & Prevention guru & the Undisputed Champion of 🫀Jeopardy @PamTaubMD!
Following the highly anticipated HORIZON trial results presented at AHA 2026, what do the findings mean for cardiovascular prevention, clinical guidelines, and everyday practice?
Dr. Pam Taub and I discuss the implications of the HORIZON findings, the evolving evidence surrounding Lp(a), and what clinicians should consider moving forward.
Watch video here: clinicaltrialresults.org/wp-…
C. Michael Gibson MD retweeted
REDUCE: Adding Spironolactone Reduces BP Over Usual Care in Stroke Patients cardiologynownews.org/?p=140…
C. Michael Gibson MD retweeted
Sotatercept Improves Rt and Lt Heart Structure and Function in HFpEF with Combined Pre- and Post-Capillary Pulmonary Hypertension
Written by
@leahkosyakovsky
More summary and analysis from #AHA2026 below: cardiologynownews.org/?p=140…
@CMichaelGibson @mpjORIORDAN @ceciliabahit
C. Michael Gibson MD retweeted
Test 2 Treat: Care Champions Do Not Significantly Improve LDL-C Lowering After MI or PCI
Written by
@GillBasir
More summary and analysis from #AHA2026 below: cardiologynownews.org/?p=140…
@CMichaelGibson @mpjORIORDAN @ceciliabahit
Following the highly anticipated HORIZON trial results presented at AHA 2026, what do the findings mean for cardiovascular prevention, clinical guidelines, and everyday practice?
Dr. Pam Taub and I discuss the implications of the HORIZON findings, the evolving evidence surrounding Lp(a), and what clinicians should consider moving forward.
Watch video here: clinicaltrialresults.org/wp-…
The recording from today's Baim Grand Rounds with Dr. Shamir Mehta titled "From COMPLETE to COMPLETE-2: Resolving the Anatomy vs. Physiology Debate in STEMI Multivessel Disease Revascularization." You can find it here: baiminstitute.org/index.php/…
Plasma proteomics can characterize #insulin resistance and provide a scalable approach to precision #cardiometabolic risk stratification. #0besity
rdcu.be/cCTVc8MVrF7a
Candles and long baths can’t fix burned-out physicians
Hospitals push doctors to engage in self-care because that’s cheaper than fixing the system
How would you fix burnout?
statnews.com/2026/11/16/doct… via @statnews
Reminder! Please join us in 30 minutes at 9:30 am EST for Baim Grand Rounds with Dr. Shamir Mehta, presenting "From COMPLETE to COMPLETE-2: Resolving the Anatomy vs. Physiology Debate in STEMI Multivessel Disease Revascularization." Zoom link: us06web.zoom.us/j/8135840252…
#BaimInstitute
C. Michael Gibson MD retweeted
CRISPR-Cas9 Gene Editing of ANGPTL3 Lowers Triglycerides in Severe Hypertriglyceridemia: Phase 1b CTX310 Trial
Written by @nkong_med
More summary and analysis from #AHA2026 below: cardiologynownews.org/?p=140…
@CMichaelGibson @mpjORIORDAN @ceciliabahit
C. Michael Gibson MD retweeted
Coordinated Nonpharmacologic Care Does Not Improve Orthostatic Intolerance in Long COVID POTS: RECOVER-AUTONOMIC
Written by @nkong_med
More summary and analysis from #AHA2026 below:
cardiologynownews.org/?p=140…
@CMichaelGibson @mpjORIORDAN @ceciliabahit
I’m at #obesityweek #OW2026 and concerned people may be a little delayed arriving for their presentations … #flightsgrounded
C. Michael Gibson MD retweeted
HELIOS-B Exercise Substudy: Vutrisiran Helped Preserve Exercise Capacity in ATTR Cardiomyopathy
Written by
@JNasrMD
More summary and analysis from #AHA2026 below: cardiologynownews.org/?p=140…
@CMichaelGibson @mpjORIORDAN @ceciliabahit
C. Michael Gibson MD retweeted
ARO-DIMER-PA: LDL-C and Triglycerides Fall After One Dose of PCSK9/APOC3 siRNA in Phase 1 Study
Written by
@GillBasir
More summary and analysis from #AHA2026 below: cardiologynownews.org/?p=140…
@CMichaelGibson @mpjORIORDAN @ceciliabahit
C. Michael Gibson MD retweeted
SHASTA-3/4 Pooled Analysis: Plozasiran's Pancreatic Benefit Greatest With Prior Pancreatitis
Written by
@GillBasir
More summary and analysis from #AHA2026 below: cardiologynownews.org/?p=140…
@CMichaelGibson @mpjORIORDAN @ceciliabahit
C. Michael Gibson MD retweeted
SRSD216: Lp(a) Remains Lower Through 1 Year After a Single Dose in Phase 1 Study
Written by
@GillBasir
More summary and analysis from #AHA2026 below: cardiologynownews.org/?p=140…
@CMichaelGibson @mpjORIORDAN @ceciliabahit















